Member States should be able to allow the exceptional use of veterinary medicinal products without a marketing authorisation where it is necessary to respond to Union-listed diseases or emerging diseases and where the health situation in a Member State so requires.
Recital 26, Regulation (EU) 2019/6
In forcesince 11 Dec 2018